Announcements Trials
Browse Landscape

Status

Recruiting 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Interventional 26Observational 5

Sponsor

Cancer Type

Gastrointestinal 18Breast 18Thoracic 13Genitourinary 11Other hematologic neoplasm 7Dermatologic 7Tumor-Agnostic 5Gynecologic 5Sarcoma 3Plasma cell 3Other solid neoplasm 2CNS 2Lymphoid 1Head & Neck 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 48Blood Specimen Collection 22Interviews as Topic 14Data Collection 11Magnetic Resonance Spectroscopy 6Hematologic Tests 6Specimen Handling 5Restraint, Physical 5Radiotherapy 5Palliative Care 4Observation 4Mental Status and Dementia Tests 4Watchful Waiting 3Registries 3Quality of Life 3Phlebotomy 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Lapatinib 3Immunotherapy 3Immune Checkpoint Inhibitors 3Health Records, Personal 3Focus Groups 3Drug Therapy 3Bevacizumab 3Absorptiometry, Photon 3veliparib 2talazoparib 2rucaparib 2pamiparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Specimen Handling × Tumor-Agnostic × Clear all
NCT06962995 2026-04-06

Multi-Cancer Detection Observational Cohort Study

Mayo Clinic

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT07131007 2026-03-23

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

Hebei Medical University Fourth Hospital

Recruiting
2,000 enrolled
Tumor-Agnostic

Neoplasms

NCT05746169 2025-12-30

Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health

University of California, San Francisco

Terminated
1,576 enrolled
Tumor-Agnostic

Neoplasms

NCT05530759 2025-04-02

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

Mayo Clinic

Recruiting
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06832150 2025-02-18

SMS2

The Wellcome Sanger Institute

Enrolling by invitation
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡